Scilex (SCLX) P/E (2021 - 2026)
Scilex (SCLX) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Scilex (SCLX) P/E is -0.18. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Scilex (SCLX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.18 | -2.48% |
| 2025 | -0.18 | -73.92% |
| 2024 | -0.70 | -69.26% |
| 2023 | -2.28 | -96.72% |
| 2022 | -69.62 | -90.78% |
| 2021 | -754.83 | N/A |
Comparison Scilex (SCLX) P/E with competitors
Scilex (SCLX) P/E is -0.18.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -5762.19% |
| PFE | Pfizer Inc | 11.65 | -6627.29% |
| NVO | Novo Nordisk | 11.79 | -6704.19% |
| GSK | GSK Plc | 12.10 | -6879.21% |
| SNY | Sanofi | 12.12 | -6890.69% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -7840.09% |
| OGN | Organon & Company | 14.33 | -8124.38% |
| BIIB | Biogen Inc | 17.41 | -9848.65% |
| GILD | Gilead Sciences Inc | 17.75 | -10038.74% |
| NVS | Novartis AG | 21.60 | -12196.17% |
| JNJ | Johnson & Johnson | 22.09 | -12471.17% |
| AMGN | AMGEN Inc | 24.75 | -13962.77% |
| MRK | Merck & Co Inc | 26.93 | -15181.45% |
| AZN | Astrazeneca plc | 28.44 | -16030.53% |
| LLY | Lilly(Eli) & Company | 48.44 | -27232.36% |
| ABBV | Abbvie Inc | 139.08 | -77997.49% |